Axfood AB (0R6R)
London Exchange · UK · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 272.70 |
|---|---|
| 52-week range | 226.50 – 338.55 |
| Return, 1 month / 3 months | +6.5% / +19.0% |
| Return, 1 year / 3 years | −1.5% / +26.6% |
| Trend | Below its 200-day average |
| RSI (14) | 75 |
| Volatility (1 year) | 25.8% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 19.76M SEK |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Axfood AB is a Swedish food retail group based in Stockholm. It runs supermarket chains, including Willys and Hemköp, that serve everyday shoppers across Sweden, and it also supplies restaurants, cafés and other businesses through its wholesale and food service operations. Its stores offer groceries, fresh produce and household goods, while its wholesale arm distributes food and related products to commercial customers. The company combines retail and distribution activities within the Swedish food market.
On this site Axfood AB appears as a stock on the London Exchange (UK), code 0R6R, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Axfood AB (0R6R) trades on the London Exchange in UK. It last closed at SEK 272.70 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,847 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.5% and over the last three months it rose 19.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -0.4% | ||
| From 52-week high | -19.5% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 19.0% | ||
| 6-month return | -14.6% | ||
| 12-month return, skipping the last month | -7.5% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 19.76M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +6.5% |
| 3 months | +19.0% |
| 6 months | −14.6% |
| 1 year | −1.5% |
| 3 years | +26.6% |
| 5 years | +51.6% |
Signals
| 50-day / 200-day average | 249.38 / 273.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | SEK 4.5000 |
| 19 Mar 2026 | SEK 4.5000 |
| 18 Sep 2025 | SEK 4.2500 |
| 20 Mar 2025 | SEK 4.5000 |
| 19 Sep 2024 | SEK 4.2500 |
| 21 Mar 2024 | SEK 4.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.